At a glance
ClinicalIndex Comparison RecordN/ACompleted· 184 enrolled
Drug / intervention
REMStar Positive Airway Pressure +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy
In Brief
A clinical study evaluating REMStar Positive Airway Pressure and LifeStyle Counseling for Sleep Apnea and Diabetes. Completed, enrolled 184 participants across 1 site.
Detailed Summary
This is a randomized control trial in people with diabetes and obstructive sleep apnea who will be randomly assigned for 3 months to PAP therapy along with healthy lifestyle and sleep education or healthy lifestyle and sleep education.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Apnea, Diabetes
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedMay 2015
Primary CompletionMar 2020
TodayJul 2026
First PostedMay 27, 2015
Enrollment StartDec 1, 2014
Primary CompletionMar 15, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11.1 years ago
Interventions
REMStar Positive Airway Pressuredevice
Positive airway pressure therapy is the standard of care for managing obstructive sleep apnea
LifeStyle Counselingbehavioral
Lifestyle guidelines developed by the American Diabetes Association for weight loss will be provided to all subjects.